An Open‐label Study Adding Creatine Monohydrate to Ongoing Medical Regimens in Patients with the Fibromyalgia Syndrome
The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Abstract
Fibromyalgia is an ill‐defined condition that causes pain and disability but still lacks effective treatment. The aim of this open‐label study was to assess the efficacy of administering a food supplement, creatine monohydrate, in an “add on” to existing therapies in patients with fibromyalgia. This study included 30 patients with fibromyalgia. After 8 weeks of receiving creatine, we witnessed a significant improvement in parameters reflecting severity of fibromyalgia, quality of life and sleep, disability, and pain. These results deteriorated 4 weeks after stopping creatine therapy. The findings of this study are preliminary and limited due to the small sample and relatively high rate of dropouts.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Sheehan, D. V., Harnett-Sheehan, K., & Raj, B. A. (1996) · International Clinical Psychopharmacology · doi:10.1097/00004850-199606003-00015 · Cited by 1,440
Arnold, L. M., Lu, Y., Crofford, L. J., Wohlreich, M., Detke, M. J., Iyengar, S., & Goldstein, D. J. (2004) · Arthritis & Rheumatism · doi:10.1002/art.20485 · Cited by 624
Arnold, L. M., Rosen, A., Pritchett, Y. L., D'Souza, D. N., Goldstein, D. J., Iyengar, S., & Wernicke, J. F. (2005) · Pain · doi:10.1016/j.pain.2005.06.031 · Cited by 471
Rae, C., Digney, A. L., McEwan, S. R., & Bates, T. C. (2003) · Proceedings of the Royal Society of London. Series B: Biological Sciences · doi:10.1098/rspb.2003.2492 · Cited by 283
Cited by
Creatine in health and disease
Kreider, R. B., & Stout, J. R. (2021) · Nutrients · doi:10.3390/nu13020447 · Cited by 227
A review of creatine supplementation in age-related diseases: more than a supplement for athletes
Smith, R. N., Agharkar, A. S., & Gonzales, E. B. (2014) · F1000Research · doi:10.12688/f1000research.5218.1 · Cited by 82
“Extensive research has demonstrated that the availability of phosphocreatine plays a role in skeletal muscle pathology and the associated pain can be alleviated by the intake of exogenous creatine 49 .”
BackgroundCreatine for the Treatment of Depression
Kious, B. M., Kondo, D. G., & Renshaw, P. F. (2019) · Biomolecules · doi:10.3390/biom9090406 · Cited by 74
“Creatine was thought to have potential as a treatment for fibromyalgia because of its benefits for muscle strength and pain [184].”
Creatine supplementation in fibromyalgia: A randomized, double-blind, placebo-controlled trial
Alves, C. R. R., Santiago, B. M., Lima, F. R., Otaduy, M. C. G., Calich, A. L., Tritto, A. C. C., de Sá Pinto, A. L., Roschel, H., Leite, C. C., Benatti, F. B., et al. (2013) · Arthritis Care & Research · doi:10.1002/acr.22020 · Cited by 73
“P R E ba se li n e; P O S T p os tt es t; ab so lu te d el ta ch an ge ;E S ef fe ct si ze ;9 5% C I 95 % co n fi d en ce in te rv al ;M M S E M in i- M en ta l S ta te E xa m in at io n . ported by Leader et al (8).”
BackgroundMethodInfluentialde Guingand, D. L., Palmer, K. R., Snow, R. J., Davies-Tuck, M. L., & Ellery, S. J. (2020) · Nutrients · doi:10.3390/nu12061780 · Cited by 35
“Two continued duration of therapy for one year [71,80] and two had populations with treatment resistant therapy, or who had previous poor treatment compliance [32,61].”
BackgroundMethodInfluential
Metadata
- Authors
- Leader, A., Amital, D., Rubinow, A., & Amital, H.
- Venue
- Annals of the New York Academy of Sciences
- Publisher
- Wiley
- Published
- 2009-09
- Volume
- 1173
- Issue
- 1
- Pages
- 829-836
- ISSN
- 0077-8923 (ISSN-L)
- 1749-6632
- OpenAlex
- W2078972453
- Cited by
- 13
- References
- 4
- FWCI
- 0.00
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: An Open‐label Study Adding Creatine Monohydrate to Ongoing Medical Regimens in Patients with the Fibromyalgia Syndrome. https://app.cochat.ai/papers/10.1111/j.1749-6632.2009.04811.x
- The paper
- Leader, A., Amital, D., Rubinow, A., & Amital, H. (2009). An Open‐label Study Adding Creatine Monohydrate to Ongoing Medical Regimens in Patients with the Fibromyalgia Syndrome. Annals of the New York Academy of Sciences. https://doi.org/10.1111/j.1749-6632.2009.04811.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.